Delivery Order SPE2DB25D3020-SPE2DB25FWKDN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,521.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100mL quantities on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cipro 5% Suspension in 100mL quantities, with a ceiling value of $3,020.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,624.01 to AmerisourceBergen Drug Corp for the supply of Cipro 5% Suspension in 100ml quantities. The contract, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, carries firm fixed pricing and represents a competitively awarded non-set-aside transaction. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,143.32 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 10% Suspension in 100ML quantities, with a ceiling value of $2,985.58 and an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a $4,205.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% suspension. This non-competitive, non-set-aside contract is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's broader federal contracting relationships. This award is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cipro 5% Suspension in 100ml quantities, with a ceiling value of $2,103.45. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The Defense Logistics Agency awarded a $2,967.88 delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities, with a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKDNDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.23 for Cipro 5% Suspension in 100ml quantities, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC supports global pharmaceutical supply requirements for military healthcare programs and serves customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill diverse medical supply requirements through open competition, with delivery orders ranging substantially in value and covering a broad spectrum of pharmaceutical products and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/21/25 |